USPTO serial 99917615
MEITHEAL
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- ABID, NABEELA
- Law office
- TMO LAW OFFICE 132
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with MEITHEAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Eric R. Moran
Eric R. Moran McDonnell Boehnen Hulbert & Berghoff LLP300 South Wacker Drive31st FloorChicago, IL 60606Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | House mark for a full line of pharmaceutical preparations; pharmaceutical preparations for treating vitamin deficiency; vitamin analogs; pharmaceutical preparations for treating vitamin B12 deficiency; vitamin B12 analogs; pharmaceutical preparations for treating vitamin B9 deficiency; vitamin B9 analogs; pharmaceutical preparations for treating anemia; pharmaceutical preparations for treating vitamin B1 deficiency; vitamin B1 analogs; diuretics; diuretic preparations; pharmaceutical preparations, namely, diuretics; pharmaceutical preparations for enhancing fertility; pharmaceutical antipsychotic preparations; pharmaceutical preparations for the treatment of psychotic disorders; pharmaceutical preparations for increasing GLP-1 levels; GLP-1 receptor agonists for treating diabetes and obesity; methylene blue to treat methemoglobinemia for medical use; dye used in medical, pharmaceutical and veterinary substances; dietetic substances for medical or veterinary purposes, namely, dietary supplements containing methylene blue, in the form of tablets or capsules, or liquid form; antifungal preparations; pharmaceutical preparations, namely, antifungal preparations; pharmaceutical preparations for treating multiple sclerosis; pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical products for treating autoimmune diseases and disorders; injectable pharmaceutical preparations for treating multiple sclerosis; syringes sold filled with injectable pharmaceutical preparations for treating multiple sclerosis; immunostimulant preparations; pharmaceutical preparations, namely, immunostimulants for increasing white blood cell production; pharmaceutical preparations for treating Paget's disease; pharmaceutical preparations for the prevention and treatment of disorders of the musculoskeletal system, namely, osteoporosis, Paget's disease, and other bone-related diseases and disorders; pharmaceutical preparations for treating osteoporosis; pharmaceutical preparations for treating and preventing hypoglycemia; Pharmaceutical preparations, namely, glucagon for diabetes related hypoglycemia, including low blood sugar, diabetes insulin shock, and insulin reaction; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for glycemic control; pharmaceutical preparations for treating systemic inflammatory conditions; pharmaceutical preparations, namely, corticosteroids | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 5, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 5, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 5, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 5, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 1, 2026 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Jul 1, 2026 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jul 1, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 1, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 1, 2026 | NWAP | NEW APPLICATION ENTERED | — |